CD55 anticorps

N° du produit ABIN2192138

L’anticorps Souris Monoclonal anti-CD55 a été validé pour WB et IA. Il convient pour détecter CD55 dans des échantillons de Porc. Il y a 1 publication disponible.

Aperçu rapide pour CD55 anticorps (ABIN2192138)

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité: Porc

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD55 est non-conjugé

Application: Western Blotting (WB), Immunoassay (IA)

Clone: PD2

Détail du produit anti-CD55 anticorps

Stérilité: 0.2 μm filtered

Information d'application

Indications d'application: For Western blotting and flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. Positive Porcine platelet lysate control

Restrictions: For Research Use only

Stockage

Buffer: PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Date de péremption: 12 months

Références pour anticorps anti-CD55 (ABIN2192138)

Pérez de la Lastra, Harris, Hinchliffe, Holt, Rushmere, Morgan: "Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 5, pp. 2563-73, (2000) (PubMed).

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: Complement Decay Accelerating Factor

Sujet: The monoclonal antibody PD2 recognizes pig complement decay accelerating factor (DAF), also designated as CD55. Cells express on their surface several proteins which protect against complement attack, namely C receptor I (CR1), decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59. CR1, DAF and MCP regulate the activation pathways of complement by either accelerating decay of the C3 and C5 convertase (CR1, DAF), or acting as cofactors for the serine protease factor I, which cleaves and irreversibly inactivates C3b (CR1, MCP). Pig DAF (CD55) is a 45-52 kDa transmembrane protein that binds C3b and C4b to inhibit formation and half-life of the C3 convertases. DAF is broadly distributed among cells in contact with serum, including both haematopoietic and nonhaematopoietic cells. Although DAF does not have an essential role in controlling hemolysis of erythrocytes, it has an important role in regulation of the deposition of C3 on nucleated cells. Together with other complement regulators DAF protects self cells from autologous complement- mediated injury. DAF cooperates with CD46 in circumventing autologous C3 deposition, while CD59 inhibits the pathway at the critical end-point. Aliases DAF, CD55 Immunogen Pig DAF-Ig fusion protein

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity